Authors:
Herrmann, SM
Funke-Kaiser, H
Schmidt-Petersen, K
Nicaud, V
Gautier-Bertrand, M
Evans, A
Kee, F
Arveiler, D
Morrison, C
Orzechowski, HD
Elbaz, A
Amarenco, P
Cambien, F
Paul, M
Citation: Sm. Herrmann et al., Characterization of polymorphic structure of cathepsin G gene - Role in cardiovascular and cerebrovascular diseases, ART THROM V, 21(9), 2001, pp. 1538-1543
Authors:
Ducimetiere, P
Signeyrole, D
Giral, P
Hoog-Labouret, N
Amarenco, P
Chanu, B
Chauvenet, M
Coletti, M
Dallongeville, J
Durlach, V
Kawka, G
Krempf, M
Leroux, G
Mlika-Cabanne, N
Monnier, L
Paillard, F
Rostoker, G
Sicard, D
Verny, C
Voiriot, P
Acquart, B
Alquier, G
Ankri, J
Badoc, G
Basdevant, A
Belmin, J
Berthezene, F
Beucler, I
Blanc, F
Broustet, JP
Bruckert, E
Brun, JM
Castaigne, A
Charpentier, JM
Andre, MC
Cogneau, J
Demeaux, JL
Denolle, T
Desson, JF
Drahi, E
Drouin, P
Dumel, F
Emmerich, J
Farnier, M
Fontbonne, A
Forette, B
Gambert, P
Gautier, JC
Guillausseau, PJ
Hommel, M
Janowski, M
Le Goaziou, MF
Lievre, M
Le Quere, M
Leys, D
Marechaud, R
Mas, JL
Menard, J
Michel, JM
Mounier-Vehier, F
Mottier, D
Passa, P
Pinel, JF
Puel, J
Raccah, D
Renou, P
Ribier, A
Schlienger, JL
Thomas, D
Vallee, JP
Veyssier-Belot, C
Bouvenot, G
Abadie, E
Alexandre, JM
Belorgey-Bismut, C
Bergmann, JF
Camelli, B
Caulin, C
Costagliola, D
Denis, C
Dupuis, B
Fleurette, F
Guillevin, L
Hoog-Labouret, N
Paintaud, G
Rauss, A
Poynard, T
Rostoker, G
Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Authors:
Heinzlef, O
Abuaf, N
Cohen, A
Amarenco, P
Citation: O. Heinzlef et al., Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study, J NEUROL, 248(5), 2001, pp. 373-379
Citation: Gw. Albers et P. Amarenco, Combination therapy with clopidogrel and aspirin - Can the CURE results beextrapolated to cerebrovascular patients?, STROKE, 32(12), 2001, pp. 2948-2949
Authors:
Hetet, G
Elbaz, A
Gariepy, J
Nicaud, V
Arveiler, D
Morrison, C
Kee, F
Evans, A
Simon, A
Amarenco, P
Cambien, F
Grandchamp, B
Citation: G. Hetet et al., Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases, EUR J CL IN, 31(5), 2001, pp. 382-388
Citation: P. Amarenco, Hypercholesterolemia, lipid lowering agents and the risk of brain infarction, DRUG THERAPY FOR STROKE PREVENTION, 2001, pp. 189-209
Authors:
Larrue, V
Amarenco, P
Caussanel, JP
Ducrocq, X
Lucas, C
Mahagne, MH
Rouanet, F
Baron, JC
Baumelou, B
Bouillat, J
Bousser, MG
Bracard, S
Chopard, JL
Dechy, H
Ellie, E
Giroud, M
Goldstein, P
Hinault, P
Hommel, M
Leys, D
Maiza, D
Mas, JL
Masson, C
Moulin, T
Mounier-Vehier, F
Rancurel, G
Trouillas, P
Leys, D
Castel, JP
Branchereau, A
Citation: V. Larrue et al., Guidelines for intravenous thrombolytic therapy in stroke victims, PRESSE MED, 29(7), 2000, pp. 372-378
Authors:
Elbaz, A
Poirier, O
Moulin, T
Chedru, F
Cambien, F
Amarenco, P
Citation: A. Elbaz et al., Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction, STROKE, 31(7), 2000, pp. 1634-1639
Authors:
Berthet, K
Lavergne, T
Cohen, A
Guize, L
Bousser, MG
Le Heuzey, JY
Amarenco, P
Citation: K. Berthet et al., Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause, STROKE, 31(2), 2000, pp. 398-403
Authors:
Larrue, V
Amarenco, P
Caussanel, JP
Ducrocq, X
Lucas, C
Mahagne, MH
Rouanet, F
Baron, JC
Baumelou, B
Boulliat, J
Bousser, MG
Bracard, S
Castel, JP
Chopard, JL
Dechy, H
Ellie, E
Giroud, M
Goldstein, P
Hinault, P
Hommel, M
Leys, D
Maiza, D
Mas, JL
Masson, C
Moulin, T
Mounier-Vehier, F
Rancurel, G
Trouillas, P
Branchereau, A
Citation: V. Larrue et al., Recommendations for using intravenous fibrinolysis in stroke patients, REV NEUROL, 156(12), 2000, pp. 1178-1185
Authors:
Vahedi, K
Domigo, V
Amarenco, P
Bousser, MG
Citation: K. Vahedi et al., Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building, J NE NE PSY, 68(1), 2000, pp. 112-113
Authors:
Elbaz, A
Poirier, O
Canaple, S
Chedru, F
Cambien, F
Amarenco, P
Citation: A. Elbaz et al., The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction, BLOOD, 95(2), 2000, pp. 586-591
Authors:
Topol, EJ
Easton, JD
Amarenco, P
Califf, R
Harrington, R
Graffagnino, C
Davis, S
Diener, HC
Ferguson, J
Fitzgerald, D
Shuaib, A
Koudstaal, PJ
Theroux, P
Van de Werf, F
Willerson, JT
Chan, R
Samuels, R
Ilson, B
Granett, J
Citation: Ej. Topol et al., Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial, AM HEART J, 139(6), 2000, pp. 927-933
Authors:
Remy, P
Zilbovicius, M
Cesaro, P
Amarenco, P
Degos, JD
Samson, Y
Citation: P. Remy et al., Primary somatosensory cortex activation is not altered in patients with ventroposterior thalamic lesions - A PET study, STROKE, 30(12), 1999, pp. 2651-2658